US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
RSS Feeds

Biotechnology Industry Research & Market Reports

10  11  12  13    15    17  18  19  
Global Food Testing Market: By Technology (Polymerase Chain Reaction, Mass Spectrometry, Chromatography, Immunoassay, Nuclear Magnetic Resonance) : By Testing Type & Geography
5/7/2014 | published by: IndustryARC
... contract laboratories and this market has been further segmented with respect to pathogens, food types and testing technologies were analyzed in this report. The market size and growth forecasts are with respect to the contract ...  |  read more...
USD 4,250
Seed Treatment Market by Type (Chemical & Non-Chemical), by Application (Fungicide, Insecticide, Bio-Control, and Others) and by Crop (Cereals, Oilseeds, and Others) - Global Trends, Forecasts and Technical Insights up to 2019
7/3/2014 | published by: MarketsandMarkets
... for seed treatment is projected to record a CAGR of 10.6% from 2014 to 2019. The estimation is a result of regular research & development in the industry, with increase in application of seed treatment ...  |  read more...
USD 4,650
Joint Reconstruction and Replacement: Materials, Technologies, and Global Markets
7/1/2014 | published by: BCC Research
... by 2018, registering a compound annual growth rate (CAGR) of 4.2% from 2013 through 2018. This report provides: An overview of the global market for joint reconstruction and replacement. Analyses of global market trends, with ...  |  read more...
USD 6,650
Global Synthetic Biology Market : 2014-2018
7/14/2014 | published by: TechNavio - Infiniti Research Ltd.
... E. I. du Pont de Nemours and Co., Thermo Fisher Scientific Inc., Synthetic Genomics Inc., Algenol Biofuels Inc., ATG:biosynthetics GmbH, Bayer AG, Bioneer Corp., Biosearch Technologies Inc., Bristol-Myers Squibb Co., CBC Comprehensive Biomarker Center GmbH, ...  |  read more...
USD 2,500
Antibodies in Oncology: Drug Pathway Analyzer 2014
7/15/2014 | published by: BioSeeker Group AB
... intracellular signaling pathways for the treatment of more than 107 different tumor types. The rational for this plethora of treatment strategies is based on our increasing understanding of the 264 drug targets that are included ...  |  read more...
USD 6,746
Biologicals in Oncology: Drug Pathway Analyzer 2014
7/15/2014 | published by: BioSeeker Group AB
... intracellular signaling pathways for the treatment of more than 137 different tumor types. The rational for this plethora of treatment strategies is based on our increasing understanding of the 547 drug targets that are included ...  |  read more...
USD 11,025
Epigenetic R&D, Therapies and Diagnostics: Industry and Market Prospects 2014-2024
6/25/2014 | published by: Visiongain
... medicines? Now get the latest analysis for that industry. There you explore developments (R&D), results, opportunities, trends and revenue forecasts. Visiongain’s updated report shows you what’s possible for those drugs, diagnostic tests and related technology. ...  |  read more...
USD 3,004
Critical Care Therapeutics in Major Developed Markets to 2020 - New and Late-Stage Four-Factor PCCs and Recombinant Products to Drive Market
7/14/2014 | published by: GBI Research
... “Critical Care Therapeutics in Major Developed Markets to 2020 - New and Late-Stage Four-Factor PCCs and Recombinant Products to Drive Market”, which provides in-depth analysis of the critical care market in the US, UK, France, ...  |  read more...
USD 4,995
RNAs (miRNA, RNAi & siRNA) in Oncology: Drug Pathway Analyzer 2014
7/15/2014 | published by: BioSeeker Group AB
... drugs known to affect more than 157 specific intracellular signaling pathways for the treatment of more than 25 different tumor types. The rational for this plethora of treatment strategies is based on our increasing understanding ...  |  read more...
USD 2,246
Neogenix Oncology, Inc. - Product Pipeline Analysis, 2014 Update
7/15/2014 | published by: GlobalData
... for the detection of tumor without destroying healthy cells. NOI’s lead product candidate includes Ensituximab, recognizes a particular epitope of tumor specific antigens from pancreatic or colorectal adenocarcinoma. The company also has two additional preclinical ...  |  read more...
USD 750
Biologicals in Oncology Drug Pipeline Update 2014
7/15/2014 | published by: BioSeeker Group AB
... developing 1686 biological drugs in 3815 developmental projects in cancer. In addition, there are 28 suspended drugs and the accumulated number of ceased drugs over the last years amount to another 932 drugs. Biologicals In ...  |  read more...
USD 11,246
Novozymes AS (NZYM B) - Financial and Strategic SWOT Analysis Review
7/1/2014 | published by: GlobalData
... you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand ...  |  read more...
USD 125
Bioxyne Limited (BXN) - Financial and Strategic SWOT Analysis Review
7/30/2014 | published by: GlobalData
... a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your ...  |  read more...
USD 125
Interleukin Genetics, Inc. (ILIU) - Financial and Strategic SWOT Analysis Review
7/30/2014 | published by: GlobalData
... you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand ...  |  read more...
USD 125
Ohmx Corporation - Product Pipeline Analysis, 2014 Update
7/15/2014 | published by: GlobalData
... diagnosis and monitoring of patients with chronic diseases. The company’s products include biosensor chip, portable POC system and laboratory biosensor reader. Ohmx develops an automated disposable cartridge that will integrate microfluidic features for sample preparation. ...  |  read more...
USD 750
Lorus Therapeutics Inc. (LOR) - Financial and Strategic SWOT Analysis Review
7/30/2014 | published by: GlobalData
... you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand ...  |  read more...
USD 125
Oxford Biodynamics Limited - Product Pipeline Analysis, 2014 Update
7/15/2014 | published by: GlobalData
... for detection, monitoring and prognosis of major diseases associated with aberrant gene expression including oncology, inflammatory, metabolic, cardiovascular and neurodegenerative conditions. Oxford Bio’s products under clinical development include OBD 27, OBD 29, OBD 35, OBD ...  |  read more...
USD 750
WHAT U.S. CONSUMERS REALLY THINK OF GMOs!
6/15/2014 | published by: Natural Marketing Institute
... past, NMI found widespread confusion about GMOs, the amount of recent media exposure on the subject has fueled consumer understanding and concerns. The objective of this current report is to provide an updated review of ...  |  read more...
USD 3,500
RNA (miRNA, RNAi & siRNA) Therapy in Oncology Drug Pipeline Update 2014
7/15/2014 | published by: BioSeeker Group AB
... molecules or protein-based therapies. There are today 58 companies plus partners developing 107 RNA (miRNA, RNAi & siRNA) drugs in 144 developmental projects in cancer. In addition, the accumulated number of ceased drugs over the ...  |  read more...
USD 4,496
EpiCast Report: Graft-Versus-Host Disease - Epidemiology Forecast to 2023
7/1/2014 | published by: GlobalData
... attack the host’s cells as foreign. GVHD can progress from mild to severe forms as either acute GVHD (aGVHD) or chronic GVHD (cGVHD). Both aGVHD and cGVHD commonly affect organs such as the skin, gastrointestinal ...  |  read more...
USD 3,995
Phosphagenics Limited : Ingredients - Company Profile, SWOT & Financial Report
5/8/2014 | published by: Canadean Ltd
... its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, business description, company history, key competitors, financial analysis, mergers & acquisitions, recent developments, key employees as well as company ...  |  read more...
USD 125
Amarantus Bioscience Holdings, Inc. (AMBS) - Product Pipeline Analysis, 2014 Update
5/14/2014 | published by: GlobalData
... offers treatment services for neurodegenerative diseases such as Parkinson’s disease, ALS and alzheimer’s disease, and cardiovascular diseases including myocardial infarction, coronary artery disease and heart failure. The company holds license to Eltoprazine, owns intellectual property ...  |  read more...
USD 750
Bioheart, Inc. (BHRT) - Product Pipeline Analysis, 2014 Update
5/14/2014 | published by: GlobalData
... Adipocell. Myocell is a muscle stem cell theraphy that intends to improve the cardiac function of a damaged heart after a severe heart attack Myocell SDF-1 is an improved version of Myocell. Here the myoblast ...  |  read more...
USD 750
BioMimetic Therapeutics, Inc. - Product Pipeline Analysis, 2014 Update
5/16/2014 | published by: GlobalData
... based upon the recombinant human platelet-derived growth factor (rhPDGF-BB) in combination with tissue specific matrices as its primary technology platform for promotion of tissue healing and regeneration. The company’s range of products and product candidates ...  |  read more...
USD 750
Caprion Inc. - Product Pipeline Analysis, 2014 Update
5/16/2014 | published by: GlobalData
... validation of biomarkers using its proteomics discovery platform CellCarta. Caprion’s CellCarta is used in profiling proteins in solid tissues and plasma. It develops in-vitro diagnostic product candidates in the areas of infectious diseases, oncology and ...  |  read more...
USD 750
10  11  12  13    15    17  18  19